Kevan Polkinghorne 🇳🇿
@dialysisbloke.bsky.social
#Nephrologist at Monashhealth
Prof of Medicine, Monash University
#Haemodialysis #BioStats #Epidemiology
Melbourne, Australia
#MedSky #NephSky #SkyNeph
Prof of Medicine, Monash University
#Haemodialysis #BioStats #Epidemiology
Melbourne, Australia
#MedSky #NephSky #SkyNeph
Reposted by Kevan Polkinghorne 🇳🇿
✅ New Clinical Guidance for Kidney Stone Management
Managing kidney stones effectively requires timely decisions and tailored evaluation. This visual summary highlights key steps from acute presentation to post-stone evaluation:
Managing kidney stones effectively requires timely decisions and tailored evaluation. This visual summary highlights key steps from acute presentation to post-stone evaluation:
December 15, 2025 at 4:54 AM
✅ New Clinical Guidance for Kidney Stone Management
Managing kidney stones effectively requires timely decisions and tailored evaluation. This visual summary highlights key steps from acute presentation to post-stone evaluation:
Managing kidney stones effectively requires timely decisions and tailored evaluation. This visual summary highlights key steps from acute presentation to post-stone evaluation:
Reposted by Kevan Polkinghorne 🇳🇿
Delighted to see my Commentary published in the latest issue of #Circulation Journal
Why We Must Rethink Kidney Transplantation as a Cardiovascular Risk–Reducing Intervention in Kidney Failure
Disagree? Happy to be challenged 💪🏼
#StopCardiacTests
Link to issue:
www.ahajournals.org/toc/circ/cur...
Why We Must Rethink Kidney Transplantation as a Cardiovascular Risk–Reducing Intervention in Kidney Failure
Disagree? Happy to be challenged 💪🏼
#StopCardiacTests
Link to issue:
www.ahajournals.org/toc/circ/cur...
Vol 152, No 23 | Circulation
www.ahajournals.org
December 8, 2025 at 9:08 PM
Delighted to see my Commentary published in the latest issue of #Circulation Journal
Why We Must Rethink Kidney Transplantation as a Cardiovascular Risk–Reducing Intervention in Kidney Failure
Disagree? Happy to be challenged 💪🏼
#StopCardiacTests
Link to issue:
www.ahajournals.org/toc/circ/cur...
Why We Must Rethink Kidney Transplantation as a Cardiovascular Risk–Reducing Intervention in Kidney Failure
Disagree? Happy to be challenged 💪🏼
#StopCardiacTests
Link to issue:
www.ahajournals.org/toc/circ/cur...
Reposted by Kevan Polkinghorne 🇳🇿
Registration now open
url.au.m.mimecastprotect.com/s/ZR0QCNLwzj...
* Causal Inference with Hidden Confounding
* Implementing the Estimand Framework in Clinical Trials
* Pairwise and Network Meta-analysis: Fundamentals and Beyond
* Cluster Randomised Trials: From Fundamentals to State-of-the-Art
url.au.m.mimecastprotect.com/s/ZR0QCNLwzj...
* Causal Inference with Hidden Confounding
* Implementing the Estimand Framework in Clinical Trials
* Pairwise and Network Meta-analysis: Fundamentals and Beyond
* Cluster Randomised Trials: From Fundamentals to State-of-the-Art
December 4, 2025 at 9:09 PM
Registration now open
url.au.m.mimecastprotect.com/s/ZR0QCNLwzj...
* Causal Inference with Hidden Confounding
* Implementing the Estimand Framework in Clinical Trials
* Pairwise and Network Meta-analysis: Fundamentals and Beyond
* Cluster Randomised Trials: From Fundamentals to State-of-the-Art
url.au.m.mimecastprotect.com/s/ZR0QCNLwzj...
* Causal Inference with Hidden Confounding
* Implementing the Estimand Framework in Clinical Trials
* Pairwise and Network Meta-analysis: Fundamentals and Beyond
* Cluster Randomised Trials: From Fundamentals to State-of-the-Art
Reposted by Kevan Polkinghorne 🇳🇿
Stop complaining about pill burden in ESRD!
There is no pill you are giving your dialysis patient that has data half as impressive as this study. If they are taking too many pills have them stop any of the dozen pills they are taking with ZEERO data in ESRD. #NephJC
There is no pill you are giving your dialysis patient that has data half as impressive as this study. If they are taking too many pills have them stop any of the dozen pills they are taking with ZEERO data in ESRD. #NephJC
December 3, 2025 at 2:51 AM
Stop complaining about pill burden in ESRD!
There is no pill you are giving your dialysis patient that has data half as impressive as this study. If they are taking too many pills have them stop any of the dozen pills they are taking with ZEERO data in ESRD. #NephJC
There is no pill you are giving your dialysis patient that has data half as impressive as this study. If they are taking too many pills have them stop any of the dozen pills they are taking with ZEERO data in ESRD. #NephJC
Reposted by Kevan Polkinghorne 🇳🇿
Maybe the most shocking study from #KidneyWk.
🐚From the depths of the oceans to #BlueSky, we're discussing PISCES 🐟 12/2/25 9pm EST. #NephJC
Are you hooked🪝on fish oil for CV disease in ESRD, or are you throwing it back 🌊?
www.nephjc.com/news/pisces-fishoil
🐚From the depths of the oceans to #BlueSky, we're discussing PISCES 🐟 12/2/25 9pm EST. #NephJC
Are you hooked🪝on fish oil for CV disease in ESRD, or are you throwing it back 🌊?
www.nephjc.com/news/pisces-fishoil
Fish Oil in Dialysis: A Big Catch or an Empty Net — NephJC
Holy Mackerel! This week we will discuss fish oil use in maintenance hemodialysis patients. Could this be the one thing that bends the curve on CV mortality, or is it just a red herring?
www.nephjc.com
December 1, 2025 at 6:41 PM
Maybe the most shocking study from #KidneyWk.
🐚From the depths of the oceans to #BlueSky, we're discussing PISCES 🐟 12/2/25 9pm EST. #NephJC
Are you hooked🪝on fish oil for CV disease in ESRD, or are you throwing it back 🌊?
www.nephjc.com/news/pisces-fishoil
🐚From the depths of the oceans to #BlueSky, we're discussing PISCES 🐟 12/2/25 9pm EST. #NephJC
Are you hooked🪝on fish oil for CV disease in ESRD, or are you throwing it back 🌊?
www.nephjc.com/news/pisces-fishoil
Reposted by Kevan Polkinghorne 🇳🇿
The International Vasculitis Workshop is pleased to announce the full speaker lineup for the 2026 event in Melbourne!
Explore the complete list and learn more about each speaker on the Workshop Website: vasculitis-melbourne2026.com/plenary-spea...
Explore the complete list and learn more about each speaker on the Workshop Website: vasculitis-melbourne2026.com/plenary-spea...
November 28, 2025 at 12:12 AM
The International Vasculitis Workshop is pleased to announce the full speaker lineup for the 2026 event in Melbourne!
Explore the complete list and learn more about each speaker on the Workshop Website: vasculitis-melbourne2026.com/plenary-spea...
Explore the complete list and learn more about each speaker on the Workshop Website: vasculitis-melbourne2026.com/plenary-spea...
Reposted by Kevan Polkinghorne 🇳🇿
The success rate for NHMRC Ideas Grants announced yesterday was just over 8%. That means 11 of every 12 people who applied got rejected. This is a culture changing level of rejection and frankly a point of national shame. This is a crisis for research.
I will not rest until we see this resolved.
I will not rest until we see this resolved.
November 26, 2025 at 8:34 PM
The success rate for NHMRC Ideas Grants announced yesterday was just over 8%. That means 11 of every 12 people who applied got rejected. This is a culture changing level of rejection and frankly a point of national shame. This is a crisis for research.
I will not rest until we see this resolved.
I will not rest until we see this resolved.
Reposted by Kevan Polkinghorne 🇳🇿
The program for the 22nd International Vasculitis Workshop has now launched!
Filled with amazing plenary speakers and sessions. Visit the website vasculitis-melbourne2026.com/program-full/ and start planning your Workshop!
Filled with amazing plenary speakers and sessions. Visit the website vasculitis-melbourne2026.com/program-full/ and start planning your Workshop!
November 26, 2025 at 2:58 AM
The program for the 22nd International Vasculitis Workshop has now launched!
Filled with amazing plenary speakers and sessions. Visit the website vasculitis-melbourne2026.com/program-full/ and start planning your Workshop!
Filled with amazing plenary speakers and sessions. Visit the website vasculitis-melbourne2026.com/program-full/ and start planning your Workshop!
Reposted by Kevan Polkinghorne 🇳🇿
Up next: It might seem a little fishy, but was a great catch 🎣 #NephJC
PISCES, the use of fish oil to decrease mortality in dialysis patients.
www.pubmed.ncbi.nlm....
PISCES, the use of fish oil to decrease mortality in dialysis patients.
www.pubmed.ncbi.nlm....
November 19, 2025 at 2:58 AM
Up next: It might seem a little fishy, but was a great catch 🎣 #NephJC
PISCES, the use of fish oil to decrease mortality in dialysis patients.
www.pubmed.ncbi.nlm....
PISCES, the use of fish oil to decrease mortality in dialysis patients.
www.pubmed.ncbi.nlm....
Reposted by Kevan Polkinghorne 🇳🇿
Mark your diaries! The ViCBiostat Summer School returns from 13-20 Feb 2026, in Melbourne and online.
Courses include causal inference, cluster randomised trials, meta-analysis and the estimand framework.
Further details TBA shortly - sign up to our mailing list at www.vicbiostat.org.au
#statistics
Courses include causal inference, cluster randomised trials, meta-analysis and the estimand framework.
Further details TBA shortly - sign up to our mailing list at www.vicbiostat.org.au
#statistics
November 12, 2025 at 4:09 AM
Mark your diaries! The ViCBiostat Summer School returns from 13-20 Feb 2026, in Melbourne and online.
Courses include causal inference, cluster randomised trials, meta-analysis and the estimand framework.
Further details TBA shortly - sign up to our mailing list at www.vicbiostat.org.au
#statistics
Courses include causal inference, cluster randomised trials, meta-analysis and the estimand framework.
Further details TBA shortly - sign up to our mailing list at www.vicbiostat.org.au
#statistics
Reposted by Kevan Polkinghorne 🇳🇿
Among more than 800 000 CKD-PC participants, discordance between cystatin C and creatinine eGFR values was associated with increased risk of death, cardiovascular events, and kidney failure.
ja.ma/47A5Gdd
ja.ma/47A5Gdd
November 11, 2025 at 12:00 PM
Among more than 800 000 CKD-PC participants, discordance between cystatin C and creatinine eGFR values was associated with increased risk of death, cardiovascular events, and kidney failure.
ja.ma/47A5Gdd
ja.ma/47A5Gdd
Reposted by Kevan Polkinghorne 🇳🇿
Final Chance!
Early bird registrations for the International Vasculitis Workshop 2026 close 14 November - and they won’t be extended again.
Register at vasculitis-melbourne2026.com/registration/
Early bird registrations for the International Vasculitis Workshop 2026 close 14 November - and they won’t be extended again.
Register at vasculitis-melbourne2026.com/registration/
November 11, 2025 at 2:21 AM
Final Chance!
Early bird registrations for the International Vasculitis Workshop 2026 close 14 November - and they won’t be extended again.
Register at vasculitis-melbourne2026.com/registration/
Early bird registrations for the International Vasculitis Workshop 2026 close 14 November - and they won’t be extended again.
Register at vasculitis-melbourne2026.com/registration/
Reposted by Kevan Polkinghorne 🇳🇿
Among more than 800 000 CKD-PC participants, discordance between cystatin C and creatinine eGFR values was associated with increased risk of death, cardiovascular events, and kidney failure.
#KidneyWK @asnkidney.bsky.social
ja.ma/4oV4DtU
#KidneyWK @asnkidney.bsky.social
ja.ma/4oV4DtU
November 7, 2025 at 8:15 PM
Among more than 800 000 CKD-PC participants, discordance between cystatin C and creatinine eGFR values was associated with increased risk of death, cardiovascular events, and kidney failure.
#KidneyWK @asnkidney.bsky.social
ja.ma/4oV4DtU
#KidneyWK @asnkidney.bsky.social
ja.ma/4oV4DtU
Reposted by Kevan Polkinghorne 🇳🇿
In PISCES, daily n–3 fatty acids cut serious cardiovascular events in dialysis patients by nearly half (HR 0.57). Fish oil clearly had bigger fish to fry than placebo: fewer MIs, strokes, cardiac deaths without extra adverse catches
@nejm.org #kidneywk sim publication
www.nejm.org/doi/full/10....
@nejm.org #kidneywk sim publication
www.nejm.org/doi/full/10....
Fish-Oil Supplementation and Cardiovascular Events in Patients Receiving Hemodialysis | NEJM
Cardiovascular disease is the leading cause of death in patients receiving hemodialysis,
yet effective preventive therapies remain limited. Supplementation with n−3 polyunsaturated
fatty acids, esp...
www.nejm.org
November 7, 2025 at 4:40 PM
In PISCES, daily n–3 fatty acids cut serious cardiovascular events in dialysis patients by nearly half (HR 0.57). Fish oil clearly had bigger fish to fry than placebo: fewer MIs, strokes, cardiac deaths without extra adverse catches
@nejm.org #kidneywk sim publication
www.nejm.org/doi/full/10....
@nejm.org #kidneywk sim publication
www.nejm.org/doi/full/10....
Reposted by Kevan Polkinghorne 🇳🇿
Shocking first high impact trial of the day. Fish oil reduces CV events in dialysis patients! #Pisces #kidneywk
Simultaneous pub in NEJM
www.nejm.org/doi/full/10....
Simultaneous pub in NEJM
www.nejm.org/doi/full/10....
November 7, 2025 at 4:45 PM
Shocking first high impact trial of the day. Fish oil reduces CV events in dialysis patients! #Pisces #kidneywk
Simultaneous pub in NEJM
www.nejm.org/doi/full/10....
Simultaneous pub in NEJM
www.nejm.org/doi/full/10....
Very proud to have lead the Australian arm of PISCES. Huge thanks for Charmaine Lok for the collaboration.
In the PISCES trial involving participants receiving hemodialysis, fish oil (n−3 fatty acids) was compared with corn-oil placebo. The rate of serious cardiovascular events was lower with daily fish-oil supplementation. Full trial results: nej.md/49zWuqo
@asnkidney.bsky.social | #KidneyWk
@asnkidney.bsky.social | #KidneyWk
November 7, 2025 at 7:38 PM
Very proud to have lead the Australian arm of PISCES. Huge thanks for Charmaine Lok for the collaboration.
Reposted by Kevan Polkinghorne 🇳🇿
Make the most of Melbourne while visiting for the 22nd International Vasculitis Workshop! Explore hidden laneway cafes, explore the coast or unwind in the Royal Botanic Gardens.
Check out the LOC Melbourne Guides: vasculitis-melbourne2026.com/loc-melbourn...
Check out the LOC Melbourne Guides: vasculitis-melbourne2026.com/loc-melbourn...
November 7, 2025 at 3:34 AM
Make the most of Melbourne while visiting for the 22nd International Vasculitis Workshop! Explore hidden laneway cafes, explore the coast or unwind in the Royal Botanic Gardens.
Check out the LOC Melbourne Guides: vasculitis-melbourne2026.com/loc-melbourn...
Check out the LOC Melbourne Guides: vasculitis-melbourne2026.com/loc-melbourn...
Reposted by Kevan Polkinghorne 🇳🇿
November 4, 2025 at 12:06 AM
Reposted by Kevan Polkinghorne 🇳🇿
We’re thrilled to welcome Professor Stephen McDonald to the International Vasculitis Workshop 2026!
A globally respected expert in vasculitis and nephrology, Prof McDonald brings invaluable insight and experience to the program.
Register today at vasculitis-melbourne2026.com
A globally respected expert in vasculitis and nephrology, Prof McDonald brings invaluable insight and experience to the program.
Register today at vasculitis-melbourne2026.com
October 16, 2025 at 11:39 PM
We’re thrilled to welcome Professor Stephen McDonald to the International Vasculitis Workshop 2026!
A globally respected expert in vasculitis and nephrology, Prof McDonald brings invaluable insight and experience to the program.
Register today at vasculitis-melbourne2026.com
A globally respected expert in vasculitis and nephrology, Prof McDonald brings invaluable insight and experience to the program.
Register today at vasculitis-melbourne2026.com
Reposted by Kevan Polkinghorne 🇳🇿
happening tomorrow!
@dialysisbloke.bsky.social will be musing on vascular access for #NephGR at @uottawa.ca and @ottawahospital.on.ca
@dialysisbloke.bsky.social will be musing on vascular access for #NephGR at @uottawa.ca and @ottawahospital.on.ca
October 8, 2025 at 9:46 PM
happening tomorrow!
@dialysisbloke.bsky.social will be musing on vascular access for #NephGR at @uottawa.ca and @ottawahospital.on.ca
@dialysisbloke.bsky.social will be musing on vascular access for #NephGR at @uottawa.ca and @ottawahospital.on.ca
Reposted by Kevan Polkinghorne 🇳🇿
Should we be considering the variability of a person's BP? Growing evidence that more variability is linked to poor outcomes. Maybe something for the 2033 BP guidelines...
Long‐Term Blood Pressure Variability and Physical Performance in Older Adults - onlinelibrary.wiley.com/doi/10.1111/...
Long‐Term Blood Pressure Variability and Physical Performance in Older Adults - onlinelibrary.wiley.com/doi/10.1111/...
onlinelibrary.wiley.com
September 17, 2025 at 4:40 PM
Should we be considering the variability of a person's BP? Growing evidence that more variability is linked to poor outcomes. Maybe something for the 2033 BP guidelines...
Long‐Term Blood Pressure Variability and Physical Performance in Older Adults - onlinelibrary.wiley.com/doi/10.1111/...
Long‐Term Blood Pressure Variability and Physical Performance in Older Adults - onlinelibrary.wiley.com/doi/10.1111/...
Reposted by Kevan Polkinghorne 🇳🇿
Last chance everyone!
Submit your abstract and join the over 55 invited international speakers at the Workshop #vasculitismelbourne2026
Case reports and series welcome
And remember the new Young Invstigator Award Session.
See you in 2026.
Submit your abstract and join the over 55 invited international speakers at the Workshop #vasculitismelbourne2026
Case reports and series welcome
And remember the new Young Invstigator Award Session.
See you in 2026.
We’re giving you more time to share your work at the upcoming International Vasculitis Workshop. The new deadline to submit your abstract is 29 September 2025!
Don't miss your opportunity, submit today at vasculitis-melbourne2026.com/call-for-abs...
Don't miss your opportunity, submit today at vasculitis-melbourne2026.com/call-for-abs...
September 18, 2025 at 5:07 AM
Last chance everyone!
Submit your abstract and join the over 55 invited international speakers at the Workshop #vasculitismelbourne2026
Case reports and series welcome
And remember the new Young Invstigator Award Session.
See you in 2026.
Submit your abstract and join the over 55 invited international speakers at the Workshop #vasculitismelbourne2026
Case reports and series welcome
And remember the new Young Invstigator Award Session.
See you in 2026.
Reposted by Kevan Polkinghorne 🇳🇿
Amazing #ANZSN meeting in Perth. First class science (🤯 young investigators), ideas for future meetings, and caught up with friends and colleagues. Melbourne for the vasculitis-melbourne2026.com next!
IVW 2026 | 22nd International Vasculitis Workshop
Join the 22nd International Vasculitis Workshop, a leading event dedicated to advancing research, treatment, and understanding of vasculitis. Connect with global experts, researchers, and practitioner...
vasculitis-melbourne2026.com
September 3, 2025 at 9:06 AM
Amazing #ANZSN meeting in Perth. First class science (🤯 young investigators), ideas for future meetings, and caught up with friends and colleagues. Melbourne for the vasculitis-melbourne2026.com next!
@nephjc.bsky.social @lastwalsh.bsky.social just presented ACHIEVE results at #ANZSN. Here’s a some details of country differences not in the main paper
September 3, 2025 at 1:43 AM
@nephjc.bsky.social @lastwalsh.bsky.social just presented ACHIEVE results at #ANZSN. Here’s a some details of country differences not in the main paper
Reposted by Kevan Polkinghorne 🇳🇿
Excellent summary of the ACHIEVE trial from @drsaivani.bsky.social & @thekidneywhisperer.bsky.social
#NephJC chat tomorrow
www.nephjc.com/news/achieve
#NephJC chat tomorrow
www.nephjc.com/news/achieve
In ESRD is spironolactone an overACHIEVEr? — NephJC
This week, we will discuss the ACHIEVE trial. Will spironolactone achieve CV benefits in ESRD?
www.nephjc.com
September 1, 2025 at 5:36 PM
Excellent summary of the ACHIEVE trial from @drsaivani.bsky.social & @thekidneywhisperer.bsky.social
#NephJC chat tomorrow
www.nephjc.com/news/achieve
#NephJC chat tomorrow
www.nephjc.com/news/achieve